Lemaitre Vascular (LMAT) EBT (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of EBT data on file, last reported at $19.7 million in Q1 2026.

• EBT for Q1 2026 came in at $19.7 million, up 38.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 million (down 90.42% YoY), and the FY2025 annual result was $154000.0, down 99.73% from the prior year.
• EBT climbed to $19.7 million in Q1 2026 per LMAT's latest filing, from -$54.7 million in the prior quarter.
• Over five years, EBT peaked at $22.6 million in Q3 2025 and troughed at -$54.7 million in Q4 2025.
• A 5-year average of $8.3 million and a median of $10.3 million in 2023 frame the typical range for EBT.
• The sharpest annual moves came in 2023 and 2025: EBT soared 85.99% in 2023, then tumbled 490.34% in 2025.
• A 5-year view of EBT shows it stood at $7.8 million in 2022, then rose by 17.9% to $9.2 million in 2023, then soared by 52.5% to $14.0 million in 2024, then plunged by 490.34% to -$54.7 million in 2025, then surged by 135.94% to $19.7 million in 2026.
• Business Quant data shows LMAT's EBT at $19.7 million in Q1 2026, -$54.7 million in Q4 2025, and $22.6 million in Q3 2025.